COMMUNIQUÉS West-GlobeNewswire

PCI Biotech: Rights issue approved by the extraordinary general meeting
14/09/2018
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]
Opthea Presents Phase 1/2a Data of OPT-302 in wet AMD at the Retina Society 2018 Annual Meeting
14/09/2018
MELBOURNE, Australia, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a late stage clinical biopharmaceutical company developing first-in-class novel biologic therapies to treat back-of-the-eye diseases, [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
14/09/2018
Company announcement - No. 22 / 2018 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 14, 2018 - Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL), a [...]
Shire plc : Rule 2.9 Announcement
14/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 September 2018 [...]
Innate Pharma reports first half 2018 financial results and business update
14/09/2018
InNate Pharma REports first Half 2018 Financial Results and Business Update Preliminary anti-tumor activity for lead asset, monalizumab, in combination with cetuximab in advanced head and neck cancer and durvalumab in [...]
Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2018
14/09/2018
InNate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2018 Données préliminaires d'activité anti-tumorale pour monalizumab, le produit le plus avancé du portefeuille, en [...]
Bone Therapeutics SA announces final results from Phase I/IIA ALLOB delayed-union fracture study
14/09/2018
Regulated information All patients met primary endpoint Optimized production process delivering critical improvements for future commercial use to be applied to all allogeneic platform clinical trials G osselies, [...]
Bone Therapeutics annonce les résultats finaux de l’étude de Phase I/IIA avec ALLOB dans les fractures avec retard de consolidation
14/09/2018
Information réglementée Tous les patients ont atteint le critère d’évaluation principal Processus de production optimisé, apportant des améliorations déterminantes en vue de la future commercialisation, appliqué à l’ [...]
Principia Biopharma Announces Pricing of Initial Public Offering
14/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Principia or the Company, Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral [...]
Scythian Biosciences Closes Acquisition of Marigold Projects Jamaica
14/09/2018
Closing Is Key Benchmark in Finalizing Previously Announced $193 Million Sale of Assets in Caribbean and Latin America Shares to Be Received in Consideration for the Proposed Sale of Assets in Caribbean and Latin [...]
Foamix Announces Pricing of its Follow-on Offering of Ordinary Shares
14/09/2018
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]
Auxly Provides Operational Update on Uruguay-Based Inverell S.A.
13/09/2018
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to provide the following operational update on the Company’s operations [...]
Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith
13/09/2018
MINNEAPOLIS, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]
3 Carbon Extractions Enters into Collaboration with CannabisWise Accreditation
13/09/2018
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that 3 Carbon Extractions Inc. ( “3 [...]
National Brain Tumor Society Responds to the 2018 Cancer Progress Report to Congress and the American Public
13/09/2018
Newton, MA , Sept. 13, 2018 (GLOBE NEWSWIRE) -- Less than two weeks after the unfortunate passing of John McCain as a result of brain cancer, the just-released American Association for Cancer Research (AACR) Cancer [...]
Globus Medical Acquires Surgimap®
13/09/2018
Cloud-based pre-operative planning accelerates advancements in Imaging, Navigation and Robotics AUDUBON, Pa., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions [...]
XBiotech annonce l’achèvement et des résultats intermédiaires positifs pour la cohorte initiale de l’étude pilote sur bermekimab dans le traitement de la dermatite atopique
13/09/2018
La société fait état de résultats positifs en termes d’innocuité et d’importantes améliorations au plan statistique chez les patients souffrant de dermatite atopique traités par faible dose de bermekimab sur une courte [...]
Supernus to Acquire Biscayne Neurotherapeutics
13/09/2018
Adds Phase 1 Novel Epilepsy Development Program ROCKVILLE, Md., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a pharmaceutical company focused on developing and commercializing [...]
Sol-Gel Technologies Names Jonathan B. Siegel to the Board of Directors
13/09/2018
NESS ZIONA, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

Pages